Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Exposure prediction and dose optimization of polymyxin B based on bayesian and machine learning.

Frontiers in pharmacology·2026
Same author

A One-Dimensional Thorium-Containing Arsenotungstate for the Synthesis of 2,3-Dihydroquinazolinones.

Inorganic chemistry·2026
Same author

Retrieval-augmented generation for medication safety: A case study using drug package inserts.

International journal of medical informatics·2026
Same author

Discovery of a New Scaffold RSK2 Inhibitor With Virtual and Phenotypical Screening.

ChemMedChem·2026
Same author

High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study.

Annals of medicine·2026
Same author

Ocular Adverse Events Associated With Antidepressants: A Large-Scale Data Analysis From the FAERS Database.

CNS neuroscience & therapeutics·2026

相关实验视频

Updated: Jun 15, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

DDInter 2.0:一个增强的药物相互作用资源,扩展数据覆盖范围,新的交互类型和改进的用户界面.

Yao Tian1, Jiacai Yi2, Ningning Wang3

  • 1Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, P.R. China.

Nucleic acids research
|August 24, 2024
PubMed
概括

DDInter 2.0增强了药物相互作用数据,包括药物-食物,药物-疾病和治疗重复. 这种全面的资源有助于医疗保健专业人员优化药物治疗和提高患者安全.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

相关实验视频

Last Updated: Jun 15, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 临床信息学 临床信息学

背景情况:

  • 药物相互作用是一个主要的临床挑战,加剧了日益增长的多药.
  • 现有的资源往往缺乏对各种相互作用类型的全面覆盖,影响患者安全和治疗疗效.

研究的目的:

  • 引入DDInter 2.0,一个扩展和增强的药物相互作用数据库.
  • 为医疗保健专业人员提供一个更完整和用户友好的资源来管理药物相互作用.

主要方法:

  • 扩展了药物相互作用数据库,包括药物与食品相互作用 (DFI),药物与疾病相互作用 (DDSI) 和治疗重复.
  • 更新了数据库,覆盖了2310种药物,包括药物相互作用 (DDI),DFI,DDSI和治疗重复的广泛记录.
  • 通过高级过来改进用户界面,以改善数据访问和分析.

主要成果:

  • 该DDInter 2.0数据库包含302516个DDI记录,其中包括8398个机制描述和管理建议.
  • 包括857个DFI,8359个DDSI和6033个治疗重复记录,所有记录都有详细的指导.
  • 具有改进的界面,用于高效的数据检索和分析.

结论:

  • DDInter 2.0为药物相互作用信息提供了一个显著增强和全面的资源.
  • 更新的数据库和改进的界面旨在支持临床决策和改善患者的治疗结果.
  • DDInter 2.0 在线免费访问,以促进广泛采用和使用.